Armata Pharmaceuticals | 4:持股变动声明-董事 PATTI JOSEPH M
Armata Pharmaceuticals | 4:持股变动声明-董事 Kramer Robin
Armata Pharmaceuticals | 4:持股变动声明-董事 Peterson Todd C.
Armata Pharmaceuticals | 4:持股变动声明-高管 Rychlik Richard
Armata Pharmaceuticals | 4:持股变动声明-董事 Schlesinger Sarah J.
Armata Pharmaceuticals | 4:持股变动声明-董事 Haimovitz Jules
Armata Pharmaceuticals | 4:持股变动声明-董事 Odysseas Kostas D
Armata Pharmaceuticals | 4:持股变动声明-高管 Birx Deborah
Armata Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Innoviva, Inc(85.3%),Innoviva Strategic Opportunities LLC(62.1%)
Armata Pharmaceuticals | 4:持股变动声明-董事 Schlesinger Sarah J.
Armata Pharmaceuticals | 4:持股变动声明-董事 Peterson Todd C.
Armata Pharmaceuticals | 4:持股变动声明-董事 Kramer Robin
Armata Pharmaceuticals | 4:持股变动声明-董事 PATTI JOSEPH M
Armata Pharmaceuticals | 4:持股变动声明-高管 Rychlik Richard
Armata Pharmaceuticals | 4:持股变动声明-董事 Haimovitz Jules
Armata Pharmaceuticals | 4:持股变动声明-首席执行官 Birx Deborah
Armata Pharmaceuticals | 4:持股变动声明-董事 Odysseas Kostas D
Armata Pharmaceuticals | 3:首次持股声明-高管 Rychlik Richard
Armata Pharmaceuticals | 3:首次持股声明-首席执行官 Birx Deborah
Armata Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Innoviva, Inc.(85.3%),Innoviva Strategic Opportunities LLC(62.1%)
暂无数据